Currently predicting for Thu, 4 Jun 2026

ATAI Prediction Chart

ATAI Predictions History

Latest community submissions for ATAI.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 22, 2019 $2.56 +11.30% $2.30 X 88.70% 0
JS JS Pro
Apr 22, 2019 $2.51 +9.13% $2.30 X 90.87% 0
Apr 22, 2019 $2.52 +9.57% $2.30 X 90.43% 0
Apr 22, 2019 $2.57 +11.74% $2.30 X 88.26% 0
Apr 22, 2019 $4.50 +95.65% $2.30 X 4.35% 0
JS JS Pro
Apr 15, 2019 $2.12 -34.77% $3.25 X 65.23% 0
Apr 15, 2019 $2.67 -17.85% $3.25 X 82.15% 0
Apr 10, 2019 $2.00 -48.05% $3.85 X 51.95% 0
Apr 10, 2019 $1.02 -73.51% $3.85 X 26.49% 0
marcos marcos @marcos.21804
Aug 29, 2018 $3.10 +28.10% $2.42 X 71.90% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ATAI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ATA INC.
ATA
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modul...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE